| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.91▲ | 11.85▲ | 11.79▲ | 11.75▲ | 12.96▼ |
| MA10 | 11.88▲ | 11.77▲ | 11.66▲ | 12.02▼ | 12.88▼ |
| MA20 | 11.86▲ | 11.62▲ | 11.56▲ | 12.85▼ | 11.40▲ |
| MA50 | 11.76▲ | 11.64▲ | 11.65▲ | 12.74▼ | 8.80▲ |
| MA100 | 11.64▲ | 11.65▲ | 12.52▼ | 11.28▲ | 12.07▼ |
| MA200 | 11.53▲ | 12.60▼ | 13.09▼ | 8.90▲ | 9.96▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.045▲ | 0.070▲ | -0.195▼ | -0.022▼ |
| RSI | 72.024▲ | 66.446▲ | 64.209▲ | 43.765▼ | 56.044▲ |
| STOCH | 63.429 | 87.961▲ | 89.486▲ | 19.814▼ | 60.009 |
| WILL %R | -11.429▲ | -3.636▲ | -2.424▲ | -74.103 | -53.176 |
| CCI | 168.431▲ | 168.223▲ | 136.708▲ | -51.941 | -20.445 |
|
Thursday, October 16, 2025 04:10 AM
Pharmaceuticals announced that the Company granted non-statutory stock options to new employees as inducement awards outside the ...
|
|
Wednesday, October 15, 2025 08:37 AM
EyePoint Pharmaceuticals outlines Phase 3 trials for Duravyu in diabetic macular edema, backed by $150 million in new funding.
|
|
Tuesday, October 14, 2025 11:10 PM
EyePoint Pharmaceuticals (NASDAQ:EYPT) has announced the pricing of an underwritten public offering expected to generate approximately $150 million in gross proceeds. The capital raise is primarily ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/10/25 | 11.73 | 11.99 | 11.52 | 11.98 | 1,121,709 |
| 23/10/25 | 11.575 | 11.575 | 11.15 | 11.50 | 1,255,055 |
| 22/10/25 | 11.90 | 12.08 | 11.31 | 11.45 | 1,528,468 |
| 21/10/25 | 12.04 | 12.205 | 11.77 | 11.81 | 1,161,146 |
| 20/10/25 | 11.75 | 12.045 | 11.20 | 12.03 | 1,406,357 |
| 17/10/25 | 11.40 | 11.655 | 11.18 | 11.63 | 1,387,330 |
| 16/10/25 | 11.80 | 12.315 | 11.45 | 11.55 | 1,976,984 |
| 15/10/25 | 13.1199 | 13.49 | 11.25 | 11.73 | 5,785,451 |
| 14/10/25 | 13.11 | 13.41 | 12.86 | 13.16 | 531,143 |
| 13/10/25 | 13.60 | 13.76 | 13.06 | 13.34 | 720,832 |
|
|
||||
|
|
||||
|
|